Legalized sports betting continues to be a polarizing issue, with many detractors expressing concerns about its potential social, ethical and economic consequences. But let’s look at how legal sports betting impacts investors.

In May 2018, the U.S. Supreme Court ruled that states can legalize sports betting, striking down the Professional and Amateur Sports Protection Act. The 1992 law banned state-authorized sports gambling, with few exceptions. Consequently, Nevada became the only state where wagers could be placed on the results of a single game. At the time, and even today, some states viewed sports betting as a potential source of tax revenue, similar to lotteries.

After the ruling, shares of several casino companies moved higher, including Caesars Entertainment (NASDAQ: CZR), which rose 6 per cent, and Penn Entertainment (NASDAQ: PENN) spiked 4 per cent. Others gains included MGM Resorts (NYSE: MGM), Boyd Gaming (NYSE: BYD) and Churchill Downs (NASDAQ: CHDN).

More recently, in 2021, the Canadian government passed Bill C-218, a federal bill allowing gambling on single sport games. Soon after the bill passed, Penn Entertainment (formerly Penn National Gaming) acquired Toronto-based Score Media in a $2 billion deal. The deal saw Score Media and Gaming shareholders getting $17 per share in cash, plus nearly 0.24 shares of common Penn Entertainment stock for each Score share, making the deal roughly half in cash.

Navigating slim margins

But legalized sports betting doesn’t just benefit gaming companies and their shareholders. Publicly traded media companies in Canada and the United States also stand to benefit from sports betting reform.

Broadcasters such as Rogers (TSE: RCI.B), Fox (NASDAQ: FOXA), Paramount (NASDAQ: PARA) and Comcast (NASDAQ: CMCSA), for example, have seen seeing subscription numbers, and traditional ratings, steadily decline since 2014 as consumers are cutting the cords and newer generations avoid cable altogether. As a result, broadcasters have seen advertising revenues also decline.

With narrowing revenue streams and increased audience fragmentation, sports betting reform has obligated broadcasters to develop new sources of revenue. For instance, media companies are capitalizing on rising casino and sports book advertising spending, as those organizations take advantage of heightened fan engagement that sports betting naturally brings.

Sports betting reform has also made room for companies, such as Disney’s ESPN, to leverage their platforms to create new digital products that deliver second-screen experiences during live sporting events.

Although these benefits haven’t completely revived the media and gaming industries, they do reposition companies in these sectors as attractive to investors looking for a calculated gamble.

While this isn’t investment advice, here’s how some of Canada’s top media and gaming companies are performing:

Be sure to stay up to date on all the latest stock market news, including company security breaches at Stockhouse.com.

Join the discussion: Find out what everybody’s saying about public companies and hot topics about stocks at Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
The Market is open sign above a group of people cheering

Futures Flat Amid Key Data in Canada and US

Thursday January 9, 2025 Investor eyes stay lazer sharp on key employment numbers from Canada and...
Breath Collection Unit

Cannabix advances marijuana breathalyzer tech

Cannabix Technologies (CSE:BLO), announced significant updates to its Cannabix marijuana breathalyzer (CMB) technology.
Location of the Abcourt property

Abcourt Mines launches Flordin property drill campaign

Abcourt Mines (TSXV:ABI) has announced the commencement of a new drilling campaign on its Flordin property.
CytoImmune Therapeutics production facility

Hemostemix stock takes off after amended manufacturing deal

Hemostemix (TSXV:HEM), a stem cell therapy stock, is up substantially after amending its manufacturing agreement with CytoImmune Therapeutics.